A comprehensive view of Evercore ISI. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
Evercore ISI upgrades Wayfair to outperform from in line and raises target by US$15 to US$80, highlighting e-commerce name's potential to steal market share as home furnishing business recovers; company's stock up 88% in last 12 months
Published:
April 04, 2024
by Schaeffer's Daily Contrarian
|
Analysts on Macy's investors reportedly offering US$5.8B to take retailer private: Evercore estimates Macy's real estate is worth US$5B-US$7B; GlobalData says if it goes private under ownership of firms focused on property, its prospects will likely dim
Published:
December 11, 2023
by Retail Dive
|
Lilly to Participate in Evercore ISI HealthCONx Conference
Published:
November 14, 2023
by Eli Lilly & Co.
|
Evercore ISI upgrades XPO to outperform from in line, raises target by US$7 to US$79, noting benefit from Yellow's liquidation, increased volumes since July and potential margin growth; new board, management changes have improved efficiency and service
Published:
September 28, 2023
by Investing.com
|
Evercore ISI upgrades CVS Health to outperform from in line and raises target by US$2 to US$83, citing improving outlook and attractive valuation, despite company cutting jobs and reducing 2024 profit forecast
Published:
September 19, 2023
by Investing.com
|
Ask us about our Health Care Sector market view